CLINIC CHARACTERISTICS, DIAGNOSTICS AND THERAPY OF MYOPERICARDITIS AND DIFFUSE MYOCARDITIS
Abstract
In study on a basement of our own research and literature data clinical course of virus myopericarditis was analyzed. Special consideration has been given to characteristics of electrocardiographic indicators, four stages of evolution of cardiographic indicators of illness were emphasized. Increase of hemorrhagic myopericarditis frequency, evidently with virus nature, was noted. Recomendations for treatment in patients suffering from myopericarditis with positive prognosis were given. At the same time, prognosis of diffuse myocarditis remains negative, and indications for its rational treatment determined insufficiently.
About the Authors
S. R. Mravjan
Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского
Russian Federation
Russian Federation
M. A. Gurevitch
Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского
Russian Federation
Russian Federation
References
1. Soler-Soler J., Permanyer-Miralda G., Sagrista-Sauleda J.A. Systematic diagnostic approach to primary acute pericardial disease.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 609-620.
2. Гогин Е.Е. Новые возможности и задачи в дифференциальной диагностике перикардитов.//Клин. медицина. 1983. № 11. С. 24-30.
3. Shabetai R. Acute pericarditis.//Cardiol. Clin. 1990. Vol. 8, N 4. P. 639-644.
4. Yoneda S., Ohte N., Samoto Т., Kobayashi Т., et al. Two cases of viral myocarditis and one case of viral pericarditis.//Jap. Circul. J. 1982. Vol. 46. P. 1222-1226.
5. B. Maisch, A.D. Ristic, S. Pankuweit. Intrapericardial treatment of autoreactive pericardial effusion with triamcinolone.//Eur. Heart J. 2002. Vol. 23. P. 1503-1508.
6. Fujioka S., Koide H., Kitaura Y., et al. Molecular detection and differentiation of enteroviruses in endomyocardial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis.//Am. Heart J. 1996. Vol. 131. P. 760-765.
7. Гогин Е.Е. Перикардиты.//Кардиология. 1991. № 2. С. 80-86.
8. Chia J.K.S., Jackson В. Myopericarditis due to parvovirus B19 in an adult.//Clin. Infect. Dis. 1996. Vol. 23. P. 200-201.
9. Orth Т., et al. Human parvovirus В19 infection associated with severe acute perimyocarditis in a 34-year-old man [letter].//Eur. Heart J. 1997. Vol. 18, N 3. P524-525.
10. Schonian U., Paul R., Gemsa D., Maisch B. Soluble interleukin-2 receptor, interleukin-6 and tumoral necrosis factor-alfa in inflammatory pericardial effusions. XVII Congr. of the Europ. Society of Card.//Eur. Heart J. 1995. Vol. 16. (abstr. Suppl.). ref. № 1711.
11. D.H. Spodick. Intrapericardial treatment of persistent autoreactive pericarditis/myopericarditis and pericardial effusion.//Eur. Heart J. 2002. Vol. 23. P. 1481-1482.
12. Бойцов С.А., Дерюгин М.В. Современные возможности диагностики неревматических миокардитов.//Consilium Medicum. 2002. Vol. 4. P. 117-124.
13. Marcolongo R., Russo R., Laveder F., Noventa F., Agostini С. Immunosuppressive therapy prevents recurrent pericarditis.//J. Am. Coll. Cardiol. 1995. Vol. 26, N 5. P. 1276-1279.
14. Гуревич М.А., Мравян С.Р., Григорьева Н.М. Особенности клиники, диагностики и лечения миоперикардитов.//Клин. медицина. 1999. № 7. С. 33-36.
15. Mason J.W., O'Connell J. B., Herskowitz N.E., et al. A clinical trial of immunosuppressive therapy for myocarditis.//New Engl. J. Med. 1995. Vol. 333. P. 269-275.
16. Hahn E.A., Hartz V.L., Moon Т.Е., et al. The Myocarditis Treatment Trial: Design, methods and patient enrolment.//Eur. Heart J. 1995. Vol. 16. P. 162-167.
17. Maisch В., Schonian U., Hengstenberg C., et al. Immunosuppressive treatment in autoreactive myocarditis -results from a controlled trial.//Postgrad. Med. J. 1994. Vol. 70 (Suppl. 1). S29-34.
18. Grag A., Shiau J., Guyatt G. The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis.//Ann. Intern. Med. 1998. Vol. 129. P. 317-322.
19. Frustaci A., Pieroni M., Chimenti C. Immunosuppressive therapy in inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 169-173.
20. Kuhl U., Pauschinger M., Noutsias M., et al. Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy.//Eur. Heart J. 2002. Vol. 4 (Suppl. l). P. 173-180.
21. Miric M., Vasiljevic J., Bojic M., et al. Long-term follow up of patients with dilated heart muscle disease treated with human leucocytic interferon alpha or thymic hormones initial results.//Heart. 1996. Vol. 75. P. 596-601.
22. Camargo P.R., Snitcowsky R., da Luz P.L., et al. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.//Pediatric Cardiol. 1995. Vol. 16. P. 61-8.
23. Schmaltz A.A., Demel K.P., Kallenberg R., et al. Immunosuppressive therapy of chronic myocarditis in children: Three cases and the design of a randomized prospective trial of therapy.//Pediatric Cardiol. 1998. Vol. 19. P. 235-239.
24. Maisch В., Hufnagel G., Schonian U., Hengstenberg. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID).//Eur. Heart J. 1995. Vol. 16 (Suppl. 0). P. 173-175.
Review
For citations:
Mravjan S.R., Gurevitch M.A. CLINIC CHARACTERISTICS, DIAGNOSTICS AND THERAPY OF MYOPERICARDITIS AND DIFFUSE MYOCARDITIS. Russian Journal of Cardiology. 2003;(5):99-103. (In Russ.)
Views:
442
Email this article 